CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C
30. August 2018 12:11 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Holdings’ Trappsol® Cyclo™ Featured in Television Program on Niemann-Pick Disease Type C
23. August 2018 08:00 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., Aug. 23, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with...
CTD Holdings Announces Expanded Access Protocol using Intravenous Trappsol® Cyclo™ for Alzheimer’s Disease
13. August 2018 08:00 ET
|
CTD Holdings, Inc.
Protocol Available on ClinicalTrials.gov ALACHUA, Fla., Aug. 13, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based...
CTD to Present at National Niemann-Pick Disease Foundation Annual Conference
27. Juni 2018 08:00 ET
|
CTD Holdings, Inc.
Conference brings together families affected by NPC from across the US ALACHUA, Fla., June 27, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB:CTDH), a clinical stage biotechnology company that...
CTD Holdings, Inc. Reports Revenue of $442,000, Representing Growth of 73.7% for the First Quarter 2012
21. Mai 2012 07:45 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., May 21, 2012 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB:CTDH) reported record quarterly revenues of $442,000 for the first quarter ended March 31, 2012, a 73.7% increase over first...
CTD Holdings, Inc. Announces That Its Form 10-Q for the First Quarter 2012 Will be Delayed Due to Administrative Reasons
11. Mai 2012 07:31 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., May 11, 2012 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB:CTDH), announced that the Company will delay the release of its Form 10-Q for the quarter ending March 31, 2012. The delay is...
CTD Holdings, Inc. - NanoSonic Products Division Signs Exclusive Distribution Agreement With Uno Healthcare
26. März 2012 07:50 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., March 26, 2012 (GLOBE NEWSWIRE) -- NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc. (OTCQB:CTDH), announced that the Company has signed an exclusive...
CTD Holdings, Inc. Reports Record Revenues for Fiscal 2011
19. März 2012 08:10 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., March 19, 2012 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB:CTDH) reported record annual revenues of $1,031,849 for the fiscal year ended December 31st, 2011, a 30% increase over 2010...
CTD Holdings, Inc. - NanoSonic Products Division Signs Manufacturing Agreement With Florida Biologix
22. Februar 2012 09:30 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., Feb. 22, 2012 (GLOBE NEWSWIRE) -- NanoSonic Products, Inc., a wholly owned subsidiary of CTD Holdings, Inc. (OTCQB:CTDH), announced that the Company has signed a manufacturing agreement...
Wall Street Resources, Inc. Releases a Research Report on CTD Holdings, Inc.
21. Februar 2012 07:50 ET
|
CTD Holdings, Inc.
ALACHUA, Fla., Feb. 21, 2012 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB:CTDH) announces the release of a Research Report on the Company, by Mr. Paul Silver, Director of Research for Wall Street...